ArticleJournal of Cancer2024

MiR-15b-3p weakens bicalutamide sensitivity in prostate cancer via targeting KLF2 to suppress ferroptosis.

Chunlin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.